of 5 Next >
Results Found: 41
  • NYU Dataset

    KaryoCreate: A CRISPR-Based Technology to Study Chromosome-Specific Aneuploidy

    Authors
    Nazario Bosco
    Aleah Goldberg
    Xin Zhao
    Joseph C. Mays
    24 more author(s)...
    Description

    This study described karyotype CRISPR engineered aneuploidy technology (KaryoCreate), a system that enables generation of chromosome-specific aneuploidies by co-expression of an sgRNA targeting chromosome-specific CENPA-binding ɑ-satellite repeats together with dCas9 fused to mutant KNL1. They designed unique and highly specific sgRNAs for 19 of the 24 chromosomes. To examine the activity of the predicted...

    Subject
    Cancer
    Genomics
    Access Rights
    Free to All
  • NYU Dataset

    Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

    Authors
    Sisi Chen
    Rahul S. Vedula
    Antonio Cuevas-Navarro
    Bin Lu
    23 more author(s)...
    Description

    This study demonstrated that loss of LZTR1, or leukemia-associated mutants in the LZTR1 substrate and RAS GTPase RIT1 that escape degradation, drives hematopoietic stem cell expansion and leukemia in vivo. For the study, genome-scale CRISPR/Cas9 screen performed in different variants of the TF-1 cell line genetically-modified to express mutant forms of RIT1 (M90I or F82C) or depleted in LZTR1 by CRISPR/Cas9,...

    Subject
    Cancer
    Genomics
    Access Rights
    Free to All
  • NYU Dataset

    RAS-Dependent Mitogen-Activated Protein Kinase Hyperactivation by Pathogenic RIT1

    Authors
    Antonio Cuevas-Navarro
    Morgan Wagner
    Richard Van
    Monalisa Swain
    11 more author(s)...
    Description

    The RAS family of small guanosine triphosphatases (GTPases) control a diverse network of signaling pathways essential for human development and adult tissue homeostasis. RAS-related GTPase RIT1 proteins promote mitogen-activated protein kinase (MAPK) hyperactivation, but this mechanism remains poorly understood. This study examined whether MEK1/2 inhibition attenuates MAPK signaling in RIT1 M90I mice...

    Subject
    Cancer
    Genomics
    Access Rights
    Free to All
  • NYU Dataset

    Proteogenomic Analysis of Cancer Aneuploidy and Normal Tissues

    Authors
    Pan Cheng
    Xin Zhao
    Lizabeth Katsnelson
    Elaine M. Camacho-Hernandez
    9 more author(s)...
    Description

    This study performed a proteogenomic analysis of DNA, RNA and protein levels across primary tumor samples and cancer cell lines from different tumor types, a panel of isogenic non-tumorigenic human colon epithelial cells and normal tissues. They found tissue specificity in the RNA-level and protein-level compensation of genes are affected by somatic copy number alterations (SCNAs). Using the DNA–RNA...

    Subject
    Cancer
    Genomics
    Proteomics
    Access Rights
    Free to All
  • National Health Interview Survey

    Alternate Title(s)
    NHIS
    Description

    The National Health Interview Survey is a cross-sectional household interview survey. Sampling and interviewing are continuous throughout each year. The sampling plan follows a multistage area probability design that permits the representative sampling of households and noninstitutional group quarters (e.g., college dormitories). NHIS addresses topics such as health status, use of health services,...

    Subject
    Cancer
    Chronic Disease
    COVID-19
    Health Care System
    Health Status
    Mental Health
    Population Characteristics
    Risk Factors
    Access Rights
    Free to All
    Fee Required
    Application Required
    Local Expert
    Lorna E. Thorpe
    Stella Yi
  • Women's Health Initiative

    Alternate Title(s)
    WHI
    Description

    The Women's Health Initiative (WHI) is a longitudinal national health study sponsored by the National Heart, Lung, and Blood Institute (NHLBI) that focuses on strategies for preventing heart disease, breast cancer, colorectal cancer, and osteoporotic fractures in postmenopausal women in the United States. The study includes data from 161,808 women aged 50-79 years old at the time of enrollment. Available...

    Subject
    Cancer
    Chronic Disease
    Genomics
    Health Status
    Mental Health
    Risk Factors
    Access Rights
    Application Required
    Local Expert
    Jeffrey S. Berger
    Lila Nachtigall
  • Nurses' Health Studies

    Alternate Title(s)
    NHS, NHS I, NHS II, NHS3, GUTS, Growing Up Today Study, GUTS
    Authors
    Frank Speizer
    Susan Hankinson
    Walter Willett
    Description

    The Nurses' Health Studies (NHS) are long-running, questionnaire-based studies on women's health. The study was initiated in 1976 with the NHS cohort. The initial studies focus on cancer, cardiovascular disease and risk factors for chronic health issues in women. The latest cohort, NH3, has been expanded to include both male and female registered nurses and nursing students. Survey and biospecimen...

    Subject
    Cancer
    Chronic Disease
    Health Status
    Population Characteristics
    Risk Factors
    Access Rights
    Fee Required
    Application Required
  • Surveillance, Epidemiology, and End Results Data

    Alternate Title(s)
    SEER
    Description

    The Surveillance, Epidemiology, and End Results (SEER) Program at the National Cancer Institute (NCI) is the authoritative source of information on cancer incidence and survival in the United States. SEER collects data on cancer incidence and population data associated by age, sex, race, year of diagnosis, and geographic area from registries across the country, covering approximately 48% of the national...

    Subject
    Cancer
    Health Status
    Population Characteristics
    Risk Factors
    Access Rights
    Free to All
    Application Required
    Local Expert
    Danil Makarov
    Judith Goldberg
    Peter Liang
  • NYU Dataset

    Physician Decision-Making During Active Surveillance of Prostate Cancer

    Authors
    Stacy Loeb
    Caitlin E. Curnyn
    Angela Fagerlin
    R. Scott Braithwaite
    4 more author(s)...
    Description

    This dataset includes structured, in-depth interviews with 24 physicians from diverse clinical backgrounds and geographic areas within the United States. These physicians were identified with purposive sampling strategies. Physicians who reported currently caring for patients through active surveillance were invited to participate. An interview guide was developed based on a literature review and previous...

    Subject
    Cancer
    Health Care System
    Timeframe
    2015
    Access Rights
    Application Required
    Author Approval Required
  • Clinical Proteomic Tumor Analysis Consortium Data

    Alternate Title(s)
    CPTAC
    Description

    The Clinical Proteomic Tumor Analysis Consortium (CPTAC) analyzes cancer biospecimens by mass spectrometry, characterizing and quantifying their constituent proteins, or proteome. Proteomic analysis for each CPTAC study is carried out independently by Proteomic Characterization Centers (PCCs) using a variety of protein fractionation techniques, instrumentation, and workflows. Mass spectrometry and...

    Subject
    Cancer
    Genomics
    Proteomics
    Access Rights
    Free to All
    Local Expert
    David Fenyo
    Kelly V. Ruggles